Sionna Therapeutics told investors its SION-719 program was on track; the Phase 2a Trial Failed Key Endpoint and stock lost roughly 90% of its value. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Sionna Therapeutics (NASDAQ: SION) shareholders watched roughly 90% of their investment disappear...
Hence then, the article about sionna therapeutics investigation notice levi korsinsky notifies investors of pending investigation into sionna therapeutics sion was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Sionna Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Sionna Therapeutics (SION) )
Also on site :
- 1956 Rock Hits, Recorded on the Same Day, Began Record 11-Week Run at No. 1 for Elvis 70 Years Ago Today
- 1957 Rock and Roll Ballad, Written by 15-Year-Old Paul Anka, Is Still a Pop Culture Staple Nearly 7 Decades Later
- Walmart's Vintage-Inspired Sideboard Has 'Plenty of Storage' and Looks Like a 'Beautiful' Antique